Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
Níall Lally, Allison C. Nugent, David A. Luckenbaugh, et al.
Translational Psychiatry (2014) Vol. 4, Iss. 10, pp. e469-e469
Open Access | Times Cited: 239

Showing 1-25 of 239 citing articles:

NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos, Ruin Moaddel, Patrick J. Morris, et al.
Nature (2016) Vol. 533, Iss. 7604, pp. 481-486
Open Access | Times Cited: 1392
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos, Ruin Moaddel, Patrick J. Morris, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 3, pp. 621-660
Open Access | Times Cited: 954
Mechanisms of ketamine action as an antidepressant
Panos Zanos, Todd D. Gould
Molecular Psychiatry (2018) Vol. 23, Iss. 4, pp. 801-811
Open Access | Times Cited: 904
A brief history of the development of antidepressant drugs: From monoamines to glutamate.
Todd M. Hillhouse, Joseph H. Porter
Experimental and Clinical Psychopharmacology (2015) Vol. 23, Iss. 1, pp. 1-21
Open Access | Times Cited: 530
Neuroscience of apathy and anhedonia: a transdiagnostic approach
Masud Husain, Jonathan P. Roiser
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 8, pp. 470-484
Open Access | Times Cited: 527
Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior
Emily Ferenczi, Kelly A. Zalocusky, Conor Liston, et al.
Science (2015) Vol. 351, Iss. 6268
Open Access | Times Cited: 502
Glutamate and Gamma-Aminobutyric Acid Systems in the Pathophysiology of Major Depression and Antidepressant Response to Ketamine
Marc S. Lener, Mark J. Niciu, Elizabeth D. Ballard, et al.
Biological Psychiatry (2016) Vol. 81, Iss. 10, pp. 886-897
Open Access | Times Cited: 414
Targeting glutamate signalling in depression: progress and prospects
James W. Murrough, Chadi G. Abdallah, Sanjay J. Mathew
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 7, pp. 472-486
Closed Access | Times Cited: 413
Treatment for Anhedonia: A Neuroscience Driven Approach
Michelle G. Craske, Alicia E. Meuret, Thomas Ritz, et al.
Depression and Anxiety (2016) Vol. 33, Iss. 10, pp. 927-938
Open Access | Times Cited: 322
Ketamine: 50 Years of Modulating the Mind
Linda Li, Phillip E. Vlisides
Frontiers in Human Neuroscience (2016) Vol. 10
Open Access | Times Cited: 319
Deep brain stimulation for treatment-resistant depression: an integrative review of preclinical and clinical findings and translational implications
Manoj P. Dandekar, Albert J. Fenoy, André F. Carvalho, et al.
Molecular Psychiatry (2018) Vol. 23, Iss. 5, pp. 1094-1112
Closed Access | Times Cited: 244
Anhedonia is associated with suicidal ideation independently of depression: A meta-analysis
Déborah Ducasse, Gwenolé Loas, Déborah Dassa, et al.
Depression and Anxiety (2017) Vol. 35, Iss. 5, pp. 382-392
Open Access | Times Cited: 213
Neural correlates of change in major depressive disorder anhedonia following open-label ketamine
Níall Lally, Allison C. Nugent, David A. Luckenbaugh, et al.
Journal of Psychopharmacology (2015) Vol. 29, Iss. 5, pp. 596-607
Open Access | Times Cited: 209
Circuit Mechanisms of Reward, Anhedonia, and Depression
Anna Höflich, Paul Michenthaler, Siegfried Kasper, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 22, Iss. 2, pp. 105-118
Open Access | Times Cited: 193
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
Nicolas D. Iadarola, Mark J. Niciu, Erica M. Richards, et al.
Therapeutic Advances in Chronic Disease (2015) Vol. 6, Iss. 3, pp. 97-114
Open Access | Times Cited: 190
Pharmacological approaches to the challenge of treatment-resistant depression
Dawn F. Ionescu, Jerrold F. Rosenbaum, Jonathan E. Alpert
Dialogues in Clinical Neuroscience (2015) Vol. 17, Iss. 2, pp. 111-126
Open Access | Times Cited: 186
Disrupted habenula function in major depression
Rebecca Lawson, Camilla L. Nord, Ben Seymour, et al.
Molecular Psychiatry (2016) Vol. 22, Iss. 2, pp. 202-208
Open Access | Times Cited: 185
Ketamine for suicidal ideation in adults with psychiatric disorders: A systematic review and meta-analysis of treatment trials
Katrina Witt, Jennifer Potts, Anna A.M. Hubers, et al.
Australian & New Zealand Journal of Psychiatry (2019) Vol. 54, Iss. 1, pp. 29-45
Open Access | Times Cited: 168
Bipolar depression: the clinical characteristics and unmet needs of a complex disorder
Roger S. McIntyre, Joseph R. Calabrese
Current Medical Research and Opinion (2019) Vol. 35, Iss. 11, pp. 1993-2005
Open Access | Times Cited: 156
Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Ioline D. Henter, Lawrence T. Park, Carlos A. Zarate
CNS Drugs (2021) Vol. 35, Iss. 5, pp. 527-543
Open Access | Times Cited: 112
Anhedonia as a central factor in depression: Neural mechanisms revealed from preclinical to clinical evidence
Shijing Wang, Francesco Leri, Sakina J. Rizvi
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 110, pp. 110289-110289
Closed Access | Times Cited: 110
Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder
Meryem Grabski, Amy McAndrew, Will Lawn, et al.
American Journal of Psychiatry (2022) Vol. 179, Iss. 2, pp. 152-162
Open Access | Times Cited: 104
Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?
Diego A. Pizzagalli
American Journal of Psychiatry (2022) Vol. 179, Iss. 7, pp. 458-469
Open Access | Times Cited: 103
Anhedonia and Depressive Disorders
Alessandro Serretti
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 401-409
Open Access | Times Cited: 57
Convergent Mechanisms Underlying Rapid Antidepressant Action
Panos Zanos, Scott M. Thompson, Ronald S. Duman, et al.
CNS Drugs (2018) Vol. 32, Iss. 3, pp. 197-227
Open Access | Times Cited: 156
Page 1 - Next Page

Scroll to top